The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia

Cancer Research

Volumn 64, Issue 10, 2004, Pages 3371-3375

  Xu, Yi ^a   Sumter, Takita Felder ^a   Bhattacharya, Raka ^a   Tesfaye, Abeba ^a   Fuchs, Ephraim J ^a   Wood, Lisa J ^a,b   Huso, David L ^a   Resar, Linda M S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University School of Nursing   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; MESSENGER RNA; T LYMPHOCYTE RECEPTOR;

ACUTE LYMPHOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA; LYMPHOMA; MALE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TRANSGENIC MOUSE;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HMGB1 PROTEIN; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LYMPHOMA; MALE; MICE; MICE, TRANSGENIC; NEOPLASM TRANSPLANTATION; RNA, MESSENGER; TRANSGENES;

EID: 2442668067     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-0044     Document Type: Article

References (20)

1. Lund T, Holtman J, Frederiksen M, Laland SJ. On the presence of two new high mobility group-like proteins in HeLa S3 cells. FEBS Lett 1983;152:163-7.
2. Johnson KR, Lehn DA, Elton TS, Barr PJ, Reeves R. The chromosomal high mobility group protein HMG-I(Y): complete murine cDNA sequence, genomic structure, and tissue expression. J Biol Chem 1988;18:18338-42.
3. Johnson KR, Cook SA, Davisson MT. Chromosomal localization of the murine gene and 2 related sequences encoding high-mobility group I and Y proteins. Genomics 1992;12:503-9.
4. Pomeroy SL, Tamayo P, Gaasenbeek M, et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature (Lond) 2002;415:436-42.
5. Saitoh Y, Laemmli UK. Metaphase chromosome structure: bands arise from a differential folding path of the highly AT-rich scaffold. Cell 1994;79:609-22.
6. Strick R, Laemmli UK. SARs are cis DNA elements of chromosome dynamics: synthesis of a SAR repressor protein. Cell 1995;83:1137-48.
7. Du W, Thanos D, Maniatis T. Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements. Cell 1993;74:887-98.
8. Munshi N, Agalioti T, Lomvardas S, et al. Coordination of transcriptional switch by HMGI(Y) acetylation. Science (Wash DC) 2002;293:1133-6.
9. Wood LJ, Mukherjee M, Dolde CE, et al. HMG-I/Y: a new c-Myc target gene and potential oncogene. Mol Cell Biol 2000;20:5409-502.
10. Wood LJ, Maher JF, Bunton TE, Resar LMS. The oncogenic properties of the HMG-I gene family. Cancer Res 2000;60:4256-61.
11. Reeves R, Edberg DD, Ying L. Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells. Mol Cell Biol 2001;21:575-94.
12. Dolde C, Mukherjee M, Cho C, Resar LMS. HMG-I/Y in human breast cancer cell lines. Breast Cancer Res Treat 2002;71:181-91.
13. Scala S, Portella G, Fedele M, Chiapetta G, Fusco A. Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias. Proc Natl Acad Sci USA 2000;85:6047-51.
14. a encoded antigens in T cell receptor Vβ8.1 chain transgenic mice. EMBO J 1989;8:719-27.
15. Malek S, Dordai DL, Reim J, Dintziz H, Desiderio S. Malignant transformation of early lymphoid progenitors in mice expressing an activated Blk tyrosine kinase. Proc Natl Acad Sci USA 1998;95:7351-6.
16. Morse HC III, Anver MR, Frederickson TN, et al. Bethesda proposals for classification of lymphoid neoplasms in mice. Blood 2002;100:246-58.
17. Pierantoni GM, Agost V, Fedele M, et al. High-mobility group A1 proteins are overexpressed in human leukaemias. Biochem J 2003;372:145-50.
18. Takaha N, Hawkins AL, Griffin CA, Isaacs WB, Coffey DS. High mobility group protein I(Y): a candidate architectural protein for chromosomal rearrangements in prostate cancer cells. Cancer Res 2002;62:647-51.
19. Adams JM, Harris AW, Pinkert CA, et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature (Lond) 1985;318:533-8.
20. Schmidt EV, Pattengale PK, Weir L, Leder P. Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: a pre-B cell lymphoma model. Proc Natl Acad Sci USA 1988;97:4256-61.